Ballentine Partners’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
Other funds holding LH
Ballentine Partners's LH Position: Q3 2026 in Review
Ballentine Partners increased its Labcorp (LH) stake by 24% in Q3 2026, buying an estimated $84.7K and bringing the position to 1,433 shares worth $442K. The position accounts for 0.01% of the portfolio, ranked #646.
Ballentine Partners first reported a position in LH in Q3 2024 and has held it in 9 quarters since. 1,007 funds tracked by Wall St. Rank hold LH as of Q3 2026.
- Ballentine Partners held 1,433 shares of Labcorp worth $442K as of Q3 2026.
- Ballentine Partners bought 273 Labcorp shares in Q3 2026, an estimated $84.7K.
- Labcorp made up 0.01% of Ballentine Partners's portfolio in Q3 2026, its #646 holding.
- Ballentine Partners first reported a position in Labcorp in Q3 2024 and has held it in 9 quarters since.
- 1,007 funds tracked by Wall St. Rank held Labcorp as of Q3 2026.
Based on Ballentine Partners's 13F filing for Q3 2026, filed 13 Nov 2026.